United Therapeutics Stock
United Therapeutics Stock
The United Therapeutics stock is trending slightly upwards today, with an increase of €3.10 (0.750%) compared to yesterday's price.
With 24 Buy predictions and 1 Sell predictions United Therapeutics is one of the favorites of our community.
With a target price of 480 € there is a slightly positive potential of 15.41% for United Therapeutics compared to the current price of 415.9 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 0.750% | -1.258% | 9.189% | 16.793% | 21.965% | 57.300% | 271.339% |
| Ironwood Pharmaceuticals | 0.640% | -5.455% | 95.000% | -6.587% | -25.714% | -73.099% | -68.163% |
| Novocure Ltd | 2.370% | -8.174% | -3.254% | -63.646% | -65.282% | -86.701% | -91.689% |
| Iovance Biotherapeutics Inc. | 0.210% | -10.811% | 19.228% | -77.316% | -72.705% | -70.951% | -94.691% |
Comments
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at UBS Group AG from $580.00 to $600.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (NASDAQ:UTHR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for UTHR provided by MarketBeat